| 10197965
|
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine replacements. |
J Med Chem |
1999 |
Dragovich PS;Prins TJ;Zhou R;Webber SE;Marakovits JT;Fuhrman SA;Patick AK;Matthews DA;Lee CA;Ford CE;Burke BJ;Rejto PA;Hendrickson TF;Tuntland T;Brown EL;Meador JW 3rd;Ferre RA;Harr JE;Kosa MB;Worland ST |
View
More |
| 10636240
|
Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitors. |
Bioorg Med Chem Lett |
2000 |
Dragovich PS;Zhou R;Webber SE;Prins TJ;Kwok AK;Okano K;Fuhrman SA;Zalman LS;Maldonado FC;Brown EL;Meador JW 3rd;Patick AK;Ford CE;Brothers MA;Binford SL;Matthews DA;Ferre RA;Worland ST |
View
More |
| 11007981
|
Characterization of the active site thiol group of rhinovirus 2A proteinase. |
FEBS Lett |
2000 |
Sarkany Z;Skern T;Polgar L |
View
More |
| 11297676
|
Analysis of the aphthovirus 2A/2B polyprotein \'cleavage\' mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal \'skip\'. |
J Gen Virol |
2001 |
Donnelly MLL;Luke G;Mehrotra A;Li X;Hughes LE;Gani D;Ryan MD |
View
More |
| 17944485
|
NMR solution structures of the apo and peptide-inhibited human rhinovirus 3C protease (Serotype 14): structural and dynamic comparison. |
Biochemistry |
2007 |
Bjorndahl TC;Andrew LC;Semenchenko V;Wishart DS |
View
More |
| 20200313
|
In situ assembly of macromolecular complexes triggered by light. |
Proc Natl Acad Sci U S A |
2010 |
Grunwald C;Schulze K;Reichel A;Weiss VU;Blaas D;Piehler J;Wiesmuller KH;Tampe R |
View
More |
| 22865380
|
Blocking human enterovirus 71 replication by targeting viral 2A protease. |
J Antimicrob Chemother |
2012 |
Falah N;Montserret R;Lelogeais V;Schuffenecker I;Lina B;Cortay JC;Violot S |
View
More |
| 23580429
|
Specificity of human rhinovirus 2A(pro) is determined by combined spatial properties of four cleavage site residues. |
J Gen Virol |
2013 |
Neubauer D;Aumayr M;Gosler I;Skern T |
View
More |
| 2444889
|
Different rhinovirus serotypes neutralized by antipeptide antibodies. |
Nature |
1987 |
McCray J;Werner G |
View
More |
| 24490888
|
Effects of daily intake of yoghurt enriched with bioactive components on chronic stress responses: a double-blinded randomized controlled trial. |
Int J Food Sci Nutr |
2014 |
Jaatinen N;Korpela R;Poussa T;Turpeinen A;Mustonen S;Merilahti J;Peuhkuri K |
View
More |
| 24649897
|
A new fusion protein platform for quantitatively measuring activity of multiple proteases. |
Microb Cell Fact |
2014 |
Zhou C;Yan Y;Fang J;Cheng B;Fan J |
View
More |
| 2557528
|
Production and properties of site-specific antibodies to synthetic peptide antigens related to potential cell surface receptor sites for rhinovirus. |
Methods Enzymol |
1989 |
McCray J;Werner G |
View
More |
| 27667485
|
Functional pharmacological characterization of SER100 in cardiovascular health and disease. |
Br J Pharmacol |
2016 |
Villar IC;Bubb KJ;Moyes AJ;Steiness E;Gulbrandsen T;Levy FO;Hobbs AJ |
View
More |
| 29980604
|
Immunoproteasomes as a novel antiviral mechanism in rhinovirus-infected airways. |
Clin Sci (Lond) |
2018 |
Dimasuay KG;Sanchez A;Schaefer N;Polanco J;Ferrington DA;Chu HW |
View
More |
| 34626801
|
Expression and purification of a cleavable recombinant fortilin from Escherichia coli for structure activity studies. |
Protein Expr Purif |
2022 |
Cantrell MS;Wall JD;Pu X;Turner M;Woodbury L;Fujise K;McDougal OM;Warner LR |
View
More |
| 7765405
|
A high capacity microbial screen for inhibitors of human rhinovirus protease 3C. |
Biotechnology (N Y) |
1994 |
McCall JO;Kadam S;Katz L |
View
More |
| 7794931
|
Peptide aldehyde inhibitors of hepatitis A virus 3C proteinase. |
Biochemistry |
1995 |
Malcolm BA;Lowe C;Shechosky S;McKay RT;Yang CC;Shah VJ;Simon RJ;Vederas JC;Santi DV |
View
More |
| 8953648
|
A peptide isolated by phage display binds to ICAM-1 and inhibits binding to LFA-1. |
Proteins |
1996 |
Welply JK;Steininger CN;Caparon M;Michener ML;Howard SC;Pegg LE;Meyer DM;De Ciechi PA;Devine CS;Casperson GF |
View
More |
| 9207196
|
Cleavage specificity of human rhinovirus-2 2A protease for peptide substrates. |
Biochem Biophys Res Commun |
1997 |
Wang QM;Sommergruber W;Johnson RB |
View
More |
| 9344409
|
A continuous colorimetric assay for rhinovirus-14 3C protease using peptide p-nitroanilides as substrates. |
Anal Biochem |
1997 |
Wang QM;Johnson RB;Cox GA;Villarreal EC;Loncharich RJ |
View
More |
| 9667969
|
Tripeptide aldehyde inhibitors of human rhinovirus 3C protease: design, synthesis, biological evaluation, and cocrystal structure solution of P1 glutamine isosteric replacements. |
J Med Chem |
1998 |
Webber SE;Okano K;Little TL;Reich SH;Xin Y;Fuhrman SA;Matthews DA;Love RA;Hendrickson TF;Patick AK;Meador JW 3rd;Ferre RA;Brown EL;Ford CE;Binford SL;Worland ST |
View
More |
| 9667970
|
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 1. Michael acceptor structure-activity studies. |
J Med Chem |
1998 |
Dragovich PS;Webber SE;Babine RE;Fuhrman SA;Patick AK;Matthews DA;Lee CA;Reich SH;Prins TJ;Marakovits JT;Littlefield ES;Zhou R;Tikhe J;Ford CE;Wallace MB;Meador JW 3rd;Ferre RA;Brown EL;Binford SL;Harr JE;DeLisle DM;Worland ST |
View
More |
| 9667971
|
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 2. Peptide structure-activity studies. |
J Med Chem |
1998 |
Dragovich PS;Webber SE;Babine RE;Fuhrman SA;Patick AK;Matthews DA;Reich SH;Marakovits JT;Prins TJ;Zhou R;Tikhe J;Littlefield ES;Bleckman TM;Wallace MB;Little TL;Ford CE;Meador JW 3rd;Ferre RA;Brown EL;Binford SL;DeLisle DM;Worland ST |
View
More |
| 9681985
|
Development of in vitro peptide substrates for human rhinovirus-14 2A protease. |
Arch Biochem Biophys |
1998 |
Wang QM;Johnson RB;Sommergruber W;Shepherd TA |
View
More |
